Olivia Capra joined FCV in 2022 as Principal. Prior to FCV, Olivia was an investor at Kaiser Permanente Ventures and Convey Capital, and was active on the boards of Ginger [now Headspace Health], Everytable, Intelycare and Protenus. Previously, Olivia led early commercial operations and growth strategy for Macro Trials and Cornerstone AI, two healthcare technology companies in the Initiate Venture Studio portfolio. Olivia started her career as an Equity Research Analyst at Barclays covering the specialty pharmaceutical sector for six years. She is a Co-Founder of The Grind, a national organization for w...read more